logo
Top Stories
56
45
racism-061618-lg.jpg

In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by...

construction-030411_19jun18.jpg

While the Commerce Department released a report on Tuesday showing a much bigger than expected jump in new residential construction in the U.S. in the month of May, the report also showed a much steeper than expected drop in building permits.

donaldtrump2-061518-lg.jpg

In a move likely to escalate the trade dispute between the U.S. and China, President Donald Trump has threatened to impose new tariffs on $200 billion worth of Chinese goods. Trump said in a statement Monday evening he has directed U.S. Trade Representative...

wallstreet1-121214_19jun18.jpg

Stocks are likely to come under pressure in early trading on Tuesday as traders worry about a trade war between the U.S. and China. The major index futures are currently pointing to a sharply lower open for the markets, with the Dow futures down by 342...

robertdeniro-trump-061318-lg.jpg

President Donald Trump has lashed out at his known critic and Hollywood actor Robert De Niro over the remarks he made during Tony Awards ceremony at the weekend. Calling Robert De Niro "a very Low IQ individual," Trump said the Oscar winner has received...

wallstreet3-121214_12jun18.jpg After ending the previous session modestly higher, stocks have shown a lack of direction over the course of morning trading on Tuesday. The Dow has been bouncing back and forth across the unchanged line after ending the previous session at its best closing level in three months.
daimler-recall-061218.jpg German auto giant Daimler has been asked to recall 238,000 Mercedes -Benz cars in Germany for use of unauthorized devices to defeat diesel emission tests. The German Transport Authority has found 774,000 Benz cars to have the unauthorized software to restrict nitrogen oxide emission. But the company has not admitted any wrongdoings.
trump-kim-summit-061218.jpg The agreement reached between US President Donald Trump and North Korean leader Kim Jong Un at a historic summit meeting in Singapore evoked mixed response in US political circles. While Vice President Mike Pence praised Trump for his steadfast leadership on the world, Republican Senator Marco Rubio has been skeptical of the deal. "While I know @potus is trying to butter him up to get a good deal
galmed-061218.jpg Shares of Galmed Pharmaceuticals Ltd. (GLMD) skyrocketed as much as 284% in early trade on Tuesday, and as of this writing are up over 180%, following encouraging top-line, 52-week results from its study dubbed ARREST.
Read More
donaldtrump2-061518.jpg In a move likely to escalate the trade dispute between the U.S. and China, President Donald Trump has threatened to impose new tariffs on $200 billion worth of Chinese goods. Trump said in a statement Monday evening he has directed U.S. Trade Representative...
Read More
paulryan-061318.jpg Apparently staving off a revolt by some moderate Republicans, House Speaker Paul Ryan, R-Wis., has said the House will consider two separate bills next week to address the young illegal immigrants known as DREAMers. The announcement by Ryan's office...
Read More
construction-030411_18jun18.jpgPartly reflecting sharply elevated lumber prices, the National Association of Home Builders released a report on Monday unexpectedly showing a deterioration in U.S. homebuilder confidence in the month of June. The report said the NAHB/Wells Fargo Housing Market Index dipped to 68 in June from 70 in May.
Read More
One of the hallmarks of Alzheimer's disease is the presence of neurofibrillary tangles inside neurons - i.e., the cells that make up the brain and the nervous system. The neurofibrillary tangles are composed of mutated Tau protein. So Tau is an attractive target for developing a new Alzheimer's therapy.
Read More
Canadian stocks are poised for a rough open Tuesday, unable to sustain gains from the previous session. Commodity prices have fallen sharply as the U.S. dollar strengthened. Rising interest rates and a brewing trade war between the U.S. and China have put a scare into global markets. Steel makers...
The New York Department of Financial Services (NYDFS) has granted BitLicense, the license of virtual currency activities, to mobile payments firm Square, Inc. to offer Bitcoin trading to New Yorkers. Square said it will "provide New Yorkers with Cash App's quick and simple way to buy and sell bitcoin." Read More
Today's Daily Dose brings you news about Royalty Pharma's investment in Biohaven Pharma; Champions Oncology's partnership with NSABP Foundation and Puma Biotechnology; upcoming regulatory catalyst of Myriad Genetics; Valeant Pharma's plaque psoriasis setback; Sarepta's presentation to watch out for the day, and FDA hold on Ziopharm's phase I trial of CD19-targeted CAR T therapy. Read More
Alexion Pharmaceuticals, Inc. (ALXN) submitted on Tuesday a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of ALXN1210, the Company's investigational long-acting C5 complement inhibitor, for the treatment... Read More
ubs-june19.jpg UBS Group AG Chief Executive Officer Sergio Ermotti said blockchain technology is almost a must for business. In an interview with CNBC, the head of the Swiss banking giant said he believes the technology is definitely an opportunity in the long term. According to him, the technology will help companies free up resources, and blockchain in particular is a great way to increase those efficiencies.
Read More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
06/19/18 10:0Official Foreign ReservesJUN 15 Mexico
06/19/18 9:0ExportsAPR P Belgium
06/19/18 9:0ImportsAPR P Belgium
06/19/18 9:0Trade BalanceAPR P Belgium
06/19/18 8:30Building Permits (M-o-M)MAY United States
06/19/18 8:30Housing Starts (M-o-M)MAY United States
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
09/16/18TEVAFremanezumab (BLA)FDA decision on Fremanezumab for the treatment of migraine
09/05/18RHHBYTECENTRIQ (sBLA)FDA decision on TECENTRIQ in combination with Avastin or bevacizumab, paclitaxel and carboplatin or chemotherapy for initial treatment of people with metastatic NSCLC
09/03/18ADMPSymjepi (sNDA)FDA decision on low dose Symjepi (0.15mg) for the emergency treatment of anaphylaxis
08/30/18AKCAVolanesorsen (NDA)FDA decision on Volanesorsen for the treatment of familial chylomicronemia syndrome (FCS).
08/28/18TTPHEravacycline (NDA) FDA decision on Eravacycline for the treatment of complicated intra-abdominal infections
View All